Novel small molecule library development

选择、获取和使用高质量的小分子文库进行筛选是药物发现和化学生物学项目的一个重要方面。随着研究人员对特定生物靶点、过程和环境的小分子适用性的进一步了解，筛选文库也在不断发展。围绕任何给定的小分子库的组成的决定都是由许多变量决定的，并且对最佳实践的意见也各不相同。任何收集的适应性都依赖于预先过滤，以避免有问题的化合物，评估适当的物理化学性质，安装理想的结构独特性水平，并确定所需的分子复杂性程度。随着学术和工业组织寻求从其筛选组合中产生不断改进的结果的集合，这些标准正在不断地进行评估和修订。实际问题包括成本、化合物管理、筛选复杂程度和分析目的也在文库组成的选择中发挥重要作用。我们的团队继续开发新的文库，包括机制询问板（MIPE）和用于单药和联合筛选平台的新型稳定代谢物文库。这些文库是研究多种疾病模型的重要工具。

The selection, acquisition and use of high-quality, small-molecule libraries for screening are an essential aspect of drug discovery and chemical biology programs. Screening libraries continue to evolve as researchers gain a greater appreciation of the suitability of small molecules for specific biological targets, processes and environments. The decisions surrounding the make-up of any given small molecule library is informed by a multitude of variables, and opinions vary on best-practices. The fitness of any collection relies upon upfront filtering to avoid problematic compounds, assess appropriate physicochemical properties, install the ideal level of structural uniqueness and determine the desired extent of molecular complexity. These criteria are under constant evaluation and revision as academic and industrial organizations seek out collections that yield ever-improving results from their screening portfolios. Practical questions including cost, compound management, screening sophistication and assay objective also play a significant role in the choice of library composition. Our team continues to develop novel libraries including the Mechanism Interrogation Plate or MIPE and a novel stable metabolite library for use in both single agent and combination screening platforms. These libraries represent important tools for studying multiple models of disease.